About US
Contact us
-
Genentech's cancer drug supply switch costs more, delays treatment, survey findsTop hospitals are still irate aboutGenentech's decision to move its best-selling cancer drugs to specialty distributors. And they're not giving up on persuading the company to change back. The latest2015/3/12
-
Which SOPs arerequired by GMP?Which SOPs arerequired by GMP? GMP要求有哪些SOP? The ECA Academy is receiving a lot of questions on SOPs (Standard Operating Procedures)needed in a GMP environment. The most interesting is the one on w2015/3/11
-
CFDA issues Administrative Measures for Food and Drug Supervision StatisticsOn December 19, 2014, China Food and Drug Administration (CFDA) issued the Administrative Measures for Food and Drug Supervision Statistics (CFDA Order No. 10). The Administrative Measures was adopted2015/3/11
-
CFDA issues Guiding Opinions on Enhancing the Construction of Food and Drug Inspection and Testing SystemTo further enhance the construction of the food and drug inspection and testing system and better play the role of inspection and testing as technical support, China Food and Drug Administration (CFDA2015/3/10
-
Drug Administration Law of the People's Republic of ChinaOrder of the President of the Peoples Republic of China (No. 45) The Drug Administration Law of the People’s Republic of China, revised at the 20th Meeting of the Standing Committee of the Ninth Nat2015/3/10
-
CFDA issues Guiding Opinions on Enhancing the Construction of Food and Drug Inspection and Testing SystemTo further enhance the construction of the food and drug inspection and testing system and better play the role of inspection and testing as technical support, China Food and Drug Administration (CFDA2015/2/4
-
Janssen and Pharmacyclics receive FDA approval for Imbruvica to treat WMJanssen Biotech and Pharmacyclics have received approval from the US Food and Drug Administration (FDA) for Imbruvica (ibrutinib) capsules as the first therapy indicated specifically for patients with2015/2/4
-
Roche's anti-PDL1 receives FDA breakthrough therapy designation to treat NSCLCThe US Food and Drug Administration (FDA) has granted second breakthrough therapy designation for Swiss drug-maker Roche's investigational cancer immunotherapy, MPDL3280A. The company has received ap2015/2/3
-
Branded drug prices leapt almost 15% last year, led by pain pills, COPD and heart medsIt's no secret that branded drugmakers often rely on price hikes to keep U.S. sales growth coming, especially on older meds whose patents are close to the ends of their lives. But according to new dat2015/1/30
-
GSK and Novartis three-part transaction receives European approvalGlaxoSmithKline (GSK) has obtained approval from the European Commission (EC) for its three-part transaction with Novartis. The deal includes the acquisition of Novartis's vaccines business, excludin2015/1/30